Table 6. Clinical data and follow up in the leprosy patients treated.
| Clinical evolution | LG (n = 57) | % |
|---|---|---|
| Improvement of skin sensitivity | 47 | 82.5 |
| Improvement of esthesiometry of hands | 18 | 31.6 |
| Worsening of hands’ esthesiometry | 3 | 5.3 |
| Improvement of esthesiometry of feet | 37 | 64.9 |
| Worsening of feet’ esthesiometry | 3 | 5.3 |
| Worsening of neurological symptoms (cramps, numbness and/or tingling) | 4 | 7.0 |
| Leprosy type 1 reaction | 1 | 1.7 |
| Neuritis | 5 | 8.8 |
| Dapsone-induced hemolytic anemia | 3 | 5.3 |
| Leprosy treatment dropout | 7 | 10.9 |
| Improvement of WHO impairment grading | 18 | 31.6 |